SBI Okasan Asset Management »

Miragen Therapeutics shares owned by SBI Okasan Asset Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by SBI Okasan Asset Management from 13F filings

Historical chart of SBI Okasan Asset Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by SBI Okasan Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by SBI Okasan Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $411k 22k 18.53

More positions owned by SBI Okasan Asset Management

Vanguard Total Stock Mkt Etf Total Stk Mkt (VTI)
Ishr Ibx Usd Hiyld Cb Etf-ui Iboxx Hi Yd Etf (HYG)
Ishares Jp Morgan Usd Emergi Jpmorgan Usd Emg (EMB)
Vanguard Ftse Developed Etf Van Ftse Dev Mkt (VEA)
Spdr Gold Minishares Trust Spdr Gld Minis (GLDM)
Vanguard Ftse Emerging Marke Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation (NVDA)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Ishares Semiconductor Etf Ishares Semicdtr (SOXX)
Apple (AAPL)
Tesla Motors (TSLA)
Amazon (AMZN)
Ss Technology Select Sector State Street Tec (XLK)
Broadcom (AVGO)

View all positions for SBI Okasan Asset Management

Top funds holding Miragen Therapeutics

FMR
BlackRock
Bellevue Group
Vanguard Group
State Street Corporation
Vanguard Capital Management
Fairmount Funds Management
VR Adviser
Paradigm Biocapital Advisors
Wellington Management Company
Citadel Advisors
Kynam Capital Management
Geode Capital Management
Balyasny Asset Management
Novo A/S

View all funds holding Miragen Therapeutics